LDS/Medical Tests/Very Long-Chain and Branched-Chain Fatty Acids Profile

Very Long-Chain and Branched-Chain Fatty Acids Profile

Very long-chain fatty acids (VLCFA) are fatty acids with a carbon chain longer than 20 carbon atoms (Docosanoic; C22:0, Tetracosanoic; C24:0 and Hexacosanoic; C26:0). Branched-chain fatty acids have a branch at a methyl group on the -carbon, and therefore cannot undergo -oxidation. Diet is an important source of very long-chain fatty acids (VLCFA) and branched-chain fatty acids. Due to their size, VLCFA are exclusively metabolized in the peroxisome to decrease carbon chain length to long-chain fatty acids (aliphatic chain with 13-21 carbon atoms), which then follow the regular mitochondrial -oxidation pathway for the generation of energy. Similarly, branched-chain fatty acids like phytanic acids, which is mostly derived from phytol of chlorophyll, first undergo α-oxidation to remove the branched-chain before it follows -oxidation. Metabolism of VLCFA and branched-chain fatty acids occurs in peroxisome, therefore, peroxisomal disorders are associated with its impaired utilization and excessive accumulation of these fatty acids. Peroxisomal disorders are genetically heterogeneous groups that result from either a defect in peroxisomal biogenesis or single peroxisomal protein defects. Zellweger syndrome, neonatal adrenoleukodystrophy (NALD), and infantile Refsum’s disease are associated with impaired biogenesis of peroxisomes while X-linked adrenoleukodystrophy (X-ALD) and peroxisomal β-oxidation-deficient (acyl-CoA oxidase1 deficiency and D-bifunctional protein deficiency) are due to mutations in peroxisomal proteins. Clinical manifestations in these disorders are caused by excessive accumulation of VLCFA and branched-chain fatty acids in various tissues, particularly the brain, liver, adrenal glands and kidney.

Biochemical abnormalities in peroxisome disorders include accumulations of VLCFA, phytanic acids and pristanic acid, therefore, measurement of these fatty acids in plasma can provide valuable information in the differential diagnosis of peroxisomal disorders. Furthermore, there is increasing evidence that VLCFA are associated with the risk of atherosclerotic cardiovascular diseases (ASCVD).

  • Aid in diagnosis and evaluating prognosis of peroxisomal disorders
  • Helps in the diagnosis of Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum’s disease, and X-linked adrenoleukodystrophy (X-ALD)
  • Useful in assessment of peroxisomal function

Increased in:

  • Zellweger syndrome
  • neonatal adrenoleukodystrophy (NALD)
  • Infantile Refsum disease,
  • Refsum disease (Phytanic acid oxidase deficiency) [Mostly phytanic acid is elevated with normal VLCFA]
  • X-linked adrenoleukodystrophy (X-ALD),
  • peroxisomal β-oxidation-deficient
Analyte Reference Range
Docosanoic acids (C22:0) < or =96.3 nmol/mL
Tetracosanoic acids (C24:0) < or =91.4 nmol/mL
Hexacosanoic acids (C26:0) < or =1.30 nmol/mL
C24:0/C22:0 RATIO < or =1.39
C26:0/C22:0 RATIO < or =0.023

 

Pristanic Acid – Age Group Reference Range
0-4 months < or =0.60 nmol/mL
5-8 months < or =0.84 nmol/mL
9-12 months < or =0.77 nmol/mL
13-23 months < or =1.47 nmol/mL
> or =24 months < or =2.98 nmol/mL

 

Phytanic Acids – Age Group Reference Range
0-4 months < or =5.28 nmol/mL
5-8 months < or =5.70 nmol/mL
9-12 months < or =4.40 nmol/mL
13-23 months < or =8.62 nmol/mL
> or =24 months < or =9.88 nmol/mL

 

Pristanic/Phytanic Ratio – Age Group Reference Range
0-4 months < or =0.35
5-8 months < or =0.28
9-12 months < or =0.23
13-23 months < or =0.24
> or =24 months < or =0.39
Gas Chromatography/Tandem Mass Spectrometer (GCMS).

Serum (Fasting 12-14 hours).

Stability

  • Ambient: 24 hours
  • Refrigerated: 7 days
  • Frozen : 28 days
X-linked adrenoleukodystrophy Full Gene Analysis, Fatty acid profiling.
3-5 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login